NCT02578771View on ClinicalTrials.gov

Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle

PHASE3CompletedINTERVENTIONAL

Enrollment

123

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions

Surgical Site Infection

Interventions

DRUG

ZuraPrep with 70% IPA

Apply topically

DRUG

ZuraPrep without 70% IPA

Apply topically. 0% IPA

DRUG

ChloraPrep CHG/IPA Teal Tint

Apply topically

OTHER

Normal Saline

Apply topically

Trial Locations (1)

20164

MicroBioTest, Sterling

All Listed Sponsors

lead

Zurex Pharma, Inc.

INDUSTRY

NCT02578771 - Pilot Clinical Evaluation to Characterize in Vivo Effects of Topically Applied ZuraPrep & ZuraPrep Vehicle | Biotech Hunter | Biotech Hunter